Skip to main content
Midas Edge

UTAH MEDICAL PRODUCTS INC

For the period ended Dec 31, 2023. Filed Mar 26, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 26, 2024

UTMD$72.86-0.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

INDEX TO FORM 10-K

PAGE
PART I
Item 1Business1
Item 1ARisk Factors15
Item 1BUnresolved Staff Comments17
Item 1CCybersecurity17
Item 2Properties17
Item 3Legal Proceedings17
Item 4Mine Safety Disclosures17
PART II
Item 5Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities18
Item 6Reserved18
Item 7Management’s Discussion and Analysis of Financial Condition and Results of Operations19
Item 7AQuantitative and Qualitative Disclosures About Market Risk33
Item 8Financial Statements and Supplementary Data33
Item 9Changes in and Disagreements With Accountants on Accounting and Financial Disclosure52
Item 9AControls and Procedures52
Item 9BOther Information52
Item 9CDisclosure Regarding Foreign Jurisdictions that Prevent Inspections52
PART III
Item 10Directors, Executive Officers and Corporate Governance53
Item 11Executive Compensation53
Item 12Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters53
Item 13Certain Relationships and Related Transactions, and Director Independence53
Item 14Principal Accounting Fees and Services53
PART IV
Item 15Exhibits, Financial Statement Schedules54
SIGNATURES55
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.